|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/127 | |
| A61K 39/39 |
| (11) | Patento numeris | 2729126 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12738679.5 |
| Europos patento paraiškos padavimo data | 2012-07-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-05-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/045829 |
| Data | 2012-07-06 |
| (87) | Numeris | WO 2013/006825 |
| Data | 2013-01-10 |
| (30) | Numeris | Data | Šalis |
| 201161505088 P | 2011-07-06 | US |
| (72) |
GEALL, Andrew, US
VERMA, Ayush, US
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | LIPOSOMES HAVING USEFUL N:P RATIO FOR DELIVERY OF RNA MOLECULES |
| LIPOSOMES HAVING USEFUL N:P RATIO FOR DELIVERY OF RNA MOLECULES |